Germany· DE-A57-e4e6106c019c50e1
Medi-Mibi
A technetium (99mtc) sestamibi product containing technetium (99mtc) sestamibi, registered in Germany by Medi-Radiopharma Kft.. The same ATC class is registered in 11 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Technetium (99mtc) sestamibi is registered in 11 of 19 countries.
Countries holding a registration under ATC V09GA01 (technetium (99mtc) sestamibi), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 6 of them publish a price we can compare per daily dose
Technetium (99mtc) sestamibi · ATC V09GA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Technetium (99mtc) Sestamibi
- Manufacturer
- Medi-Radiopharma Kft.
- Country
- Germany (DE)
- ATC code
- V09GA01
- ATC class
- Technetium (99mTc) sestamibi
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Technetium (99mtc) sestamibi in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- Japanヘキサキスメトキシイソブチルイソニトリルテクネチウム（９９ｍＴｃ）ＰＤＲファーマ
- United StatesKit for the Preparation of Technetium Tc99m SestamibiCardinal Health 414, LLC
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Austria · Medi-Mibi
- Denmark · Medi-Mibi
- Spain · Mibi
- Hungary · Cardio-Spect
- Italy · Medi-Mibi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cfd0b7c8-4785-4bdc-9677-64e1f496fc8c GET /v1/drugs/cfd0b7c8-4785-4bdc-9677-64e1f496fc8c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Technetium (99mtc) Sestamibi",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about technetium (99mtc) sestamibi.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.